Exome Asset Management LLC — VERA THERAPEUTICS INC VERA: Quarterly 13F Position History
Exome Asset Management LLC has reported VERA THERAPEUTICS INC (VERA) on 4 13F-HR filings in Pactolio's tracked window, first appearing in Q2 2025. As of Q1 2026, the position is sized at 114,991 shares ($4.6M market value, 2.72% of the equity book). Quarter-over-quarter share count change: 9,400 (-7.6%) .
- 114,991Shares Held (Latest Filing)
- $4.6MReported Market Value (Latest Filing)
- 2.72%Portfolio Weight (% of 13F Equity Book)
- 9,400Quarter-over-Quarter Share Change
- -$1.7MQuarter-over-Quarter Value Change
- 156,072Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 114,991 | 9,400 | -7.6% | $4.6M | 2.72% | $40.23 |
| Q4 2025 | 124,391 | 31,681 | -20.3% | $6.3M | 3.11% | $50.64 |
| Q3 2025 | 156,072 | +79,372 | +103.5% | $4.5M | 2.99% | $29.06 |
| Q2 2025 | 76,700 | — | — | $1.8M | 1.49% | $23.56 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Exome Asset Management LLC first disclose a VERA position in 13F-HR filings?
Exome Asset Management LLC first reported VERA THERAPEUTICS INC (VERA) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.
What was Exome Asset Management LLC's most recent quarter-over-quarter share-count change in VERA?
Between Q4 2025 and Q1 2026, Exome Asset Management LLC reduced its VERA position by 9,400 shares (-7.6%), leaving 114,991 shares at a market value of $4.6M.
Does the implied price-per-share represent Exome Asset Management LLC's cost basis in VERA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.